Cellusion

Cellusion is a regenerative medicine startup that was born in 2015 at the Department of Ophthalmology of Keio University School of Medicine. Cellusion aims to address unmet medical needs through its cutting-edge cell therapy technologies, including a unique differentiation induction method from iPS cells to CECSi cells, thereby contributing to the improvement of health and well-being around the world. Cellusion's mission is to provide users with a clear vision of the future through breakthroughs in cellular technology.